Bausch Health Companies | VRX - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
Amgen USD 6.89B 415M 2025-12
ANI Pharmaceuticals USD 124.18M 12.39M 2025-12
Aurora Cannabis CAD 46.62M 14.33M 2025-12
Bausch Health Companies USD 2B 67M 2025-12
Biogen USD 1.82B 169.5M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Canopy Growth CAD 21.47M 434K 2025-12
Corcept Therapeutics USD 162.02M 37.56M 2026-03
Danaher USD 3.59B 375M 2026-03
Drreddys Laboratories INR 46.81B 10.24B 2025-12
Eli Lilly USD 15.92B 1.33B 2025-12
Gilead Sciences USD 5.52B 791M 2026-03
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Novo Nordisk DKK 64.01B 1.19B 2025-06
Pacira USD 126.64M 15.61M 2026-03
Perrigo USD 325.5M 36.7M 2026-03
Phibro Animal Health USD 133.5M 12.6M 2025-12
Prestige Brands USD 157.37M 5.79M 2025-12
Supernus Pharmaceuticals USD 129.36M 34.68M 2026-03
Vertex Pharmaceuticals USD 2.6B 121.7M 2026-03
Zoetis USD 1.62B 20M 2026-03